ChemoCentryx, Inc. (CCXI) Q3 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to the Chemocentric's third quarter 2021 financial results conference call. At this time, all participants are in a listen-only mode. Later on, we will conduct a question and answer session. As a reminder, this conference call will be recorded. I'll now turn the call over to Lee Roth of Burns MacLellan. Mr. Roth, please go ahead. Thanks, Jesse. Good afternoon and welcome to the Chemocentrics third quarter 2021 financial results conference call. Earlier this afternoon, the company issued a press release providing an overview of its financial results for the quarter ended September 30th, 2021. This release, along with a few slides that you may find helpful while you listen to the call, are available on the investor relations section of the company's website at chemocentrics.com. Joining us on the call today is Dr. Thomas Schall, President and Chief Executive Officer of Chemocentrics. who will review the company's recent business and clinical progress. Following his comments, Susan Kanaya, Executive Vice President, Chief Financial and Administrative Officer of ChemoCentrics, will provide an overview of the company's financial highlights for the quarter before turning the call back to Tom for closing remarks. During today's call, we'll be making certain forward-looking statements. As explained on slide two, these forward-looking statements are based on current information, assumptions, and expectations that are subject to change and involve a number of risks and uncertainties It may cause our actual results to differ materially from those contained in the forward-looking statements. These risks are described in the company's filings made with the Securities and Exchange Commission, including our annual report on Form 10-K filed on March 1st, 20...